- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/78 - Benzo [b] furansHydrogenated benzo [b] furans
Patent holdings for IPC class C07D 307/78
Total number of patents in this class: 140
10-year publication summary
|
6
|
6
|
9
|
2
|
5
|
5
|
10
|
8
|
8
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5731 |
6 |
| Daewoong Pharmaceutical Co., Ltd. | 366 |
5 |
| LG Chem, Ltd. | 17937 |
3 |
| AstraZeneca AB | 2820 |
3 |
| Green Cross Corporation | 220 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 851 |
3 |
| Toyama Chemical Co., Ltd. | 88 |
3 |
| Sanofi | 4316 |
3 |
| Tactogen Inc | 40 |
3 |
| BASF SE | 21318 |
2 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| Allergan, Inc. | 2162 |
2 |
| The Board of Trustees of the University of Illinois | 2747 |
2 |
| Dainippon Sumitomo Pharma Co., Ltd. | 166 |
2 |
| Katholieke Universiteit Leuven | 1292 |
2 |
| Kissei Pharmaceutical Co., Ltd. | 177 |
2 |
| Ohio State Innovation Foundation | 2383 |
2 |
| The Scripps Research Institute | 1342 |
2 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 715 |
2 |
| Board of Regents of The University of Texas System, Austin | 2 |
2 |
| Other owners | 86 |